Condition: Parkinsons Disease (PD) · Sponsor: Sanford Health
The investigators hypothesize that multi-session anodal tDCS (atDCS) of the left primary motor cortex (M1) will induce long-lasting effects in improving motor function and reducing motor fatigue and fatigability in PD patients.
This description comes directly from the study's public registry record.
Jessica Keller, B.S. · 701-417-5781 · jessica.keller@sanfordhealth.org
Always discuss trial participation with your own doctor first.
| Sanford Brain and Spine Center | Fargo, North Dakota, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06883266